https://dev-www.gatchealth.com/articles/ 2026-05-15T00:36:41+00:00 https://dev-www.gatchealth.com/articles/benefits-and-risks-of-stem-cells-a-comprehensive-review/ 2025-11-03T16:59:16+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/04/Benefits-and-Risks-of-Stem-Cells-A-Comprehensive-Review-v2.png https://dev-www.gatchealth.com/articles/short-peptides-may-be-the-key-to-long-life/ 2025-11-03T17:17:32+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/03/Short-Peptides-May-be-the-Key-to-Long-Life-v2.png https://dev-www.gatchealth.com/articles/multiomics-experimental-design-for-drug-discovery/ 2025-11-03T17:20:39+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/01/Multiomics-Experimental-Design-for-Drug-Discovery.png https://dev-www.gatchealth.com/articles/islet-transplantation-using-ones-own-differentiated-stem-cells-a-review-and-potential-applications/ 2025-11-03T17:27:43+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/01/Islet-Transplantation-using-ones-own-Differentiated-stem-cells-A-Review-and-Potential-Applications.png https://dev-www.gatchealth.com/articles/novel-artificial-intelligence-based-approaches-to-the-mitigation-and-treatment-of-post-traumatic-stress-disorder-ptsd-in-affected-populations/ 2025-11-03T17:41:18+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2024/12/Novel-Artificial-Intelligencebased-Approaches-to-the-Mitigation-and-Treatment-of-PostTraumatic-Stress-Disorder-PTSD-in-Affected-Populations.png https://dev-www.gatchealth.com/articles/learning-to-discover-the-impact-of-ai-in-preclinical-drug-development/ 2025-11-03T17:44:59+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2024/11/Learning-to-Discover-The-Impact-of-AI-in-Preclinical-Drug-Development-V2.png https://dev-www.gatchealth.com/articles/ai-based-predictions-of-molecular-target-activity-from-blind-chemical-structures/ 2025-11-03T17:46:57+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2024/06/AIBased-Predictions-of-Molecular-Target-Activity-from-Blind-Chemical-Structures.png https://dev-www.gatchealth.com/articles/peptide-neuromodulation-in-autism-spectrum-disorder-targeting-neuroinflammation-mitochondrial-dysfunction-and-synaptic-plasticity/ 2025-12-04T22:05:22+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/05/Peptide-Neuromodulation-in-Autism-Spectrum-Disorder-Targeting-Neuroinflammation-Mitochondrial-Dysfunction-and-Synaptic-Plasticity.png https://dev-www.gatchealth.com/articles/ai-driven-drug-development-a-capital-efficient-model-for-the-future-of-precision-medicine/ 2026-01-02T20:58:49+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/10/GATC_FPO-replacement-2.png https://dev-www.gatchealth.com/articles/gatc-health-comments-on-fdas-draft-guidance-for-use-of-ai/ 2026-01-02T21:15:00+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/01/GATC-Health-Comments-on-FDAs-Draft-Guidance-for-Use-of-AI-V2.png https://dev-www.gatchealth.com/articles/ai-derived-therapeutic-development-for-the-treatment-of-opioid-use-disorder/ 2026-01-02T21:17:12+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2024/02/AI-Derived-Therapeutic-Development-for-the-Treatment-of-Opioid-Use-Disorder-v3.png https://dev-www.gatchealth.com/articles/future-of-precision-medicine-artificial-intelligence-guided-polypharmacology-and-rational-polypharmacy-interventions/ 2026-01-02T21:19:30+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2024/01/Future-of-Precision-Medicine-Artificial-Intelligence-Guided-Polypharmacology-and-Rational-Polypharmacy-Interventions-V3.png https://dev-www.gatchealth.com/articles/exosomes-a-potential-source-of-biomarkers-therapy-and-cure-for-type-1-diabetes/ 2026-01-02T21:20:22+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2023/10/Exosomes-a-Potential-Source-of-Biomarkers-Therapy-and-Cure-for-Type1-Diabetes.png https://dev-www.gatchealth.com/articles/machine-learning-and-augmented-intelligence-enables-prognosis-of-type-2-diabetes-prior-to-clinical-manifestation/ 2026-01-02T21:26:47+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2024/02/Machine-Learning-and-Augmented-Intelligence-Enables-Prognosis-of-Type-2-Diabetes-Prior-to-Clinical-Manifestation.png https://dev-www.gatchealth.com/articles/autologous-antigen-specific-immunotherapy-aasi-precision-immune-re-education-in-autoimmunity-and-beyond/ 2026-01-08T18:25:41+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/10/GATC_FPO-replacement-2.png https://dev-www.gatchealth.com/articles/restoring-the-degenerating-brain-mesenchymal-and-neural-stem-cells-in-neurotherapeutics/ 2026-01-08T22:45:37+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/10/GATC_FPO-replacement-2.png https://dev-www.gatchealth.com/articles/gatc-health-and-uci-to-showcase-breakthrough-opioid-use-disorder-drug-candidate-at-society-for-neuroscience-s-2025-conference/ 2026-01-09T15:12:17+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/10/GATC_FPO-replacement-2.png https://dev-www.gatchealth.com/articles/biosimilar-trial-failed-investors-get-their-money-back-a-new-insurance-model-redefines-clinical-trial-financing/ 2026-01-09T16:51:04+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2025/10/GATC_FPO-replacement-2.png https://dev-www.gatchealth.com/articles/autologous-cardiac-stem-cell-therapy-current-evidence-mechanisms-and-emerging-directions/ 2026-01-31T01:09:29+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2026/01/Autologous-Cardiac-Stem-Cell-Therapy.jpg https://dev-www.gatchealth.com/articles/a-historical-journey-through-pharmacology-total-synthesis-and-evolution-towards-iboga-alkaloid-analogs/ 2026-03-09T16:51:29+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2026/03/A-Historical-Journey-through-Pharmacology-Total-Synthesis-and-Evolution-Towards-Iboga-Alkaloid-Analogs.png https://dev-www.gatchealth.com/articles/ai-derived-therapeutic-development-of-a-serotonin-receptor-targeting-drug-for-the-treatment-of-opioid-use-disorder/ 2026-04-13T19:48:00+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2026/04/PNAS-Image-2-1021.png https://dev-www.gatchealth.com/articles/harnessing-ai-to-revolutionize-drug-discovery/ 2026-04-22T23:32:14+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2026/04/Harnessing-AI-to-Revolutionize-Drug.png https://dev-www.gatchealth.com/articles/operon-platform-enabled-for-cardiometabolic-biomarker-screening-and-precision-treatment-strategies-a-type-2-diabetes-centered-review-with-cardiovascular-extension/ 2026-04-29T19:44:06+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2026/04/Operon%E2%84%A2-Platform-Enabled-for-Cardiometabolic-Biomarker-Screening-and-Precision-Treatment-Strategies-A-Type-2-Diabetes-Centered-Review-with-Cardiovascular-Extension.png https://dev-www.gatchealth.com/articles/ai-enabled-identification-of-histaminergic-mechanisms-underlying-infusion-related-dermatologic-reactions-to-a-targeted-oncolytic-peptide/ 2026-04-29T19:45:13+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2026/04/AI-Enabled-Identification-of-Histaminergic.png https://dev-www.gatchealth.com/articles/a-multi-scale-evidence-orchestrated-digital-twin-architecture-for-therapeutic-development-a-systems-theoretic-framework/ 2026-05-08T00:18:40+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2026/05/A-Multi-Scale-Evidence-Orchestrated-Digital-Twin-Architecture-for-Therapeutic-Development-A-Systems-Theoretic-Framework.png https://dev-www.gatchealth.com/articles/the-multi-omics-profiling-of-early-passage-mesenchymal-stem-cell-exosomes-reveals-potential-targets-for-attenuating-diabetic-inflammatory-pathophysiology/ 2026-05-15T00:36:41+00:00 http://dev-www.gatchealth.com/wp-content/uploads/2026/05/The-Multi-Omics-Profiling-of-Early-Passage-Mesenchymal-Stem-Cell-Exosomes-Reveals-Potential-Targets-for-Attenuating-Diabetic-Inflammatory-Pathophysiology.png